Stay updated on HKI-272 for HER2+ Breast Cancer and Brain Metastases Clinical Trial
Sign up to get notified when there's something new on the HKI-272 for HER2+ Breast Cancer and Brain Metastases Clinical Trial page.

Latest updates to the HKI-272 for HER2+ Breast Cancer and Brain Metastases Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 from the history.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedAdded a new revision entry (v3.4.2) and removed the previous revision (v3.4.1) from the study history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check39 days agoChange DetectedA new revision entry v3.4.1 was added to the study history and v3.4.0 was removed, updating the version listing without altering core study data. This reflects an adjustment to the revision history rather than substantive content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check46 days agoChange DetectedThe record history shows the trial moving to Completed and adds Adverse Events and related status updates, while the previous status Active, not recruiting was removed.SummaryDifference0.4%

- Check61 days agoChange DetectedA new revision entry for v3.3.4 was added to the Record History, and the previous entry v3.3.3 was removed, reflecting a minor update to the site's revision log. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check75 days agoChange DetectedAdded a new Revision: v3.3.3 entry on the history page and removed the HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer. These are administrative updates to release notes and footer links.SummaryDifference0.1%

Stay in the know with updates to HKI-272 for HER2+ Breast Cancer and Brain Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HKI-272 for HER2+ Breast Cancer and Brain Metastases Clinical Trial page.